{"id":75128,"date":"2020-10-01T16:10:00","date_gmt":"2020-10-01T16:10:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2736928"},"modified":"2020-10-01T16:10:00","modified_gmt":"2020-10-01T16:10:00","slug":"global-stroke-management-market-set-for-rapid-growth-to-reach-value-usd-42-53-billion-by-2025","status":"publish","type":"post","link":"http:\/\/ipsnews.net\/business\/2020\/10\/01\/global-stroke-management-market-set-for-rapid-growth-to-reach-value-usd-42-53-billion-by-2025\/","title":{"rendered":"Global Stroke Management Market Set for Rapid Growth, to reach Value USD 42.53 billion by 2025"},"content":{"rendered":"

Zion Market Research has published a new report titled “Stroke Management Market by Type (Therapeutics and Diagnostics) and Application (Hemorrhagic Stroke and Ischemic Stroke): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025” According to the report, global demand for Stroke Management market<\/a> was valued at approximately USD 26.13 billion in 2018, and is expected to generate revenue of around USD 42.53 billion by end of 2025, growing at a CAGR of around 7.3% between 2019 and 2025.<\/p>\n

\"Stroke<\/p>\n

 <\/p>\n

A stroke occurs when blood stream is blocked to the brain, or after bursting and bleeding of blood vessel. The obstruction stops blood and oxygen from reaching the brain’s tissues. The absence of blood and oxygen results in demise of brain cells. The stroke prompted due to obstruction of blood flow to the brain is called ischemic stroke. Whereas, the stroke instigated due to blood vessel bursting is termed as hemorrhagic stroke. Furthermore, a third kind of stroke, is activated due to a momentary clot and is called transient ischemic attack (TIA). According to CDC, stroke is the 5th important basis of death in the U.S. Every year, around 795,000 persons in U.S. have a stroke.<\/p>\n

Request For Free Sample Report @https:\/\/www.zionmarketresearch.com\/sample\/stroke-management-market<\/a><\/strong><\/p>\n

Factors such as growing elderly population, rising tobacco use, escalating prevalence of prolonged diseases, introduction of new medical products, and quick progress in diabetes cases will act as foremost driving features in the growth of global stroke management market. High focus on research and development of stroke management products and continual technological advances will act as an opportunity for the market players in the stroke management market. Nonetheless, hefty conventions by government, scarcity of skilled physicians and diagnosticians will restrict the growth of global stroke management market.<\/p>\n

The global stroke management market has been split into application, type. The application segment has been divided into ischemic stroke and hemorrhagic. The ischemic stroke accounted for the maximum market share in 2018 owing to growing occurrence of ischemic stroke cases.<\/p>\n

Based on type, stroke management market has been segmented into diagnostics and therapeutics. The diagnostics segment made up the maximum market share in 2018 owing to increasing use of diagnostic examinations such as MRI and CT scan. The therapeutics segment has been further divided into antiplatelet, tissue plasminogen activator, antihypertensive, and anticoagulant. The diagnostics segment has been further divided into magnetic resonance imaging (MRI), computed tomography scan (CT scan), cerebral angiography, echocardiography, carotid ultrasound, electrocardiography, and others.<\/p>\n

Regionally, the breast milk substitutes market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. U.S. accounted for the highest share in the North America region due to presence of latest healthcare setup as well as skilled physicians and high per capita healthcare spending. Europe is expected to be the second major market. The key reasons are favorable reimbursement scenario, increase in geriatric population, and increasing investment by major players. Asia Pacific will grow at rapid rate over the forecast time-frame due to large patient pool, heavy use of tobacco, increasing prevalence of chronic diseases, and major improvements in the healthcare facilities. The Latin America region will grow at a significant rate during the assessment period. The Middle East & Africa region is expected to exhibit definite progression in the anticipated time-frame.<\/p>\n

The report also includes detailed profiles of key players such as Koninklijke Philips N.V., ZOLL Medical Corporation, Mizuho America Inc., Stryker Corporation, and Genentech Inc. among others.<\/p>\n

This report segments the Global Stroke Management Market as follows:<\/strong><\/p>\n

Global Stroke Management Market: By Type<\/strong><\/p>\n